Evaluation of a Therapeutic Interchange from Fluticasone/Salmeterol to Mometasone/Formoterol in Patients with Chronic Obstructive Pulmonary Disease

BACKGROUND: Combination treatment with an inhaled corticosteroid and long-acting beta2-agonist is among the many treatment options for chronic obstructive pulmonary disease (COPD) that has been shown to improve clinical outcomes. While mometasone/formoterol does not currently have an FDA-approved in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yip, Elaine, Karimi, Sahar, T. Pien, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398114/
https://www.ncbi.nlm.nih.gov/pubmed/27023685
http://dx.doi.org/10.18553/jmcp.2016.22.4.316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398114/
https://www.ncbi.nlm.nih.gov/pubmed/27023685
http://dx.doi.org/10.18553/jmcp.2016.22.4.316

Ejemplares similares